With Zero Revenue, Laekna Plays Chicken-And-Egg Game With Investors
The biotechnology company, which is facing ballooning losses without any revenue like many of its peers, has filed for an IPO in Hong Kong (more…)
RELATED ARTICLES
- Funding boost gets Sunho Biologics over the IPO filing line
-
GenScript losses shrink on strong growth for cancer cell therapy
1548.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
Adlai Nortye dives in Nasdaq debut, as key product faces hurdles
ANL.US
-
Sales success comes with side effects for drug maker BeiGene
BGNE.US 6160.HK
-
HBM gets health boost from drug licensing deals
2142.HK
-
Cash-strapped Viva Biotech sells stake and plans spinoff
1873.HK
Discover hidden China stock gems in our weekly newsletter